Carroll Financial Associates’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$4K Hold
48
﹤0.01% 1398
2021
Q3
$6K Hold
48
﹤0.01% 1349
2021
Q2
$7K Hold
48
﹤0.01% 1383
2021
Q1
$8K Sell
48
-48
-50% -$11.1K ﹤0.01% 1275
2020
Q4
$19K Sell
96
-2
-2% -$407 ﹤0.01% 942
2020
Q3
$21K Hold
98
﹤0.01% 850
2020
Q2
$18K Sell
98
-55
-36% -$9.64K ﹤0.01% 887
2020
Q1
$23K Buy
153
+2
+1% +$233 ﹤0.01% 754
2019
Q4
$12K Hold
151
﹤0.01% 1003
2019
Q3
$10K Sell
151
-59
-28% -$3.88K ﹤0.01% 1015
2019
Q2
$13K Hold
210
﹤0.01% 936
2019
Q1
$11K Buy
210
+59
+39% +$3.6K ﹤0.01% 925
2018
Q4
$7K Buy
+151
New +$9.24K ﹤0.01% 959

Other funds holding TDOC

Carroll Financial Associates's TDOC Position: Q4 2021 in Review

Carroll Financial Associates held its Teladoc Health (TDOC) position steady in Q4 2021 at 48 shares worth $4K. The position accounts for ﹤0.01% of the portfolio, ranked #1398.

Carroll Financial Associates first reported a position in TDOC in Q4 2018 and has held it in 13 quarters since. The position peaked at $23K in Q1 2020. 729 funds tracked by Wall St. Rank hold TDOC as of Q4 2021.

  • Carroll Financial Associates held 48 shares of Teladoc Health worth $4K as of Q4 2021.
  • Carroll Financial Associates left its Teladoc Health share count unchanged in Q4 2021.
  • Teladoc Health made up ﹤0.01% of Carroll Financial Associates's portfolio in Q4 2021, its #1398 holding.
  • Carroll Financial Associates first reported a position in Teladoc Health in Q4 2018 and has held it in 13 quarters since.
  • Carroll Financial Associates's Teladoc Health position peaked at $23K in Q1 2020.
  • 729 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2021.

Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.